HealthMode
San Francisco
About HealthMode
HealthMode delivers AI-enabled digital measurement methods to increase the precision and speed of clinical research, and improve healthcare. HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its client partners represent a diverse set of stakeholders, from clinical researchers and drug developers at large pharmaceutical companies, to academic medical centers, to startups entering the space. HealthMode's measurement techniques improve understanding of phenotype; streamline and provide assurance for screening and eligibility; provide early detection and mitigation of adverse events; and serve as a sensitive, specific, objective, and low participant burden efficacy endpoints. These measurements allow for meaningful integration of clinical trial data with real-world evidence and provide the basis for movement toward patient-specific measures. Better measurement tools and the platforms to support them help HealthMode's partners make data-informed decisions, reduce uncertainty around enrollment and outcomes, de-risk development, and increase the speed at which novel therapeutics reach patients in need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $3.5M
- Funding stage: M&A
- Last round: Seed (Oct 2017)
- Website: healthmode.com
Industries & Categories
Artificial Intelligence (AI), Health Care, Information Technology, Machine Learning, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/healthmode-175516 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.